CHAPIN DAVIS, INC.

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 872098 BALTIMORE, MD

Position in ALNY

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$255,875

-$23,379 QoQ

Shares Held

850

+0.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#53

of 105 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CHAPIN DAVIS, INC. holds $1,662,100 across 5 Biotechnology names. ALNY ranks #3 (15.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DYAI	Dyadic International Inc	888,004	$799,203
2	TRVI	Trevi Therapeutics, Inc.	20,100	$374,865
3	ALNY	Alnylam Pharmaceuticals, Inc. This page	850	$255,875
4	BEAM	Beam Therapeutics Inc.	6,000	$205,920
5	LCTX	Lineage Cell Therapeutics, Inc.	20,029	$26,237

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$255,875	850	+0.7%	Shares	Sole	2026-07-07
2026-03-31	$279,254	844	+2.3%	Shares	Sole	2026-04-21
2025-12-31	$328,061	825	0.0%	Shares	Sole	2026-01-30
2025-09-30	$376,200	825	0.0%	Shares	Sole	2025-10-09
2025-06-30	$269,024	825	0.0%	Shares	Sole	2025-07-14
2025-03-31	$222,766	825	0.0%	Shares	Sole	2025-04-23
2024-12-31	$194,130	825	0.0%	Shares	Sole	2025-01-21
2024-09-30	$226,899	825	0.0%	Shares	Sole	2024-10-07
2024-06-30	$200,475	825	—	Shares	Sole	2024-07-19
No filing history on record for this holder in this stock.